Subjects: United States - Digital Collections - National Library of Medicine Search Results

Start Over Subjects United States ✖

31. HHS's Office of Refugee Resettlement improved coordination and outreach to promote the safety and well-being of unaccompanied alien children

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2017
Subject(s):: Child Welfare
Emigrants and Immigrants
Emigration and Immigration
Refugees
Child
Child Abuse -- prevention & control
Human Trafficking -- prevention & control
Safety
Humans
United States
United States. Department of Health and Human Services.
United States. Department of Homeland Security.

32. Medicare program shared savings accountable care organizations have shown potential for reducing spending and improving quality

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2017
Subject(s):: Accountable Care Organizations
Cost Savings
Cost Sharing
Medicare
Quality of Health Care
Cost Control
Facilities and Services Utilization -- statistics & numerical data
Fee-for-Service Plans
Health Expenditures
Quality Indicators, Health Care
Humans
United States
United States. Department of Health and Human Services.

33. Colorado State Medicaid Fraud Control Unit: 2016 onsite review

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2017
Subject(s):: Fraud -- prevention & control
Medicaid
Federal Government
State Government
Humans
Colorado
United States
United States. Department of Health and Human Services.

34. FDA oversight of tobacco manufacturing establishments

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2017
Subject(s):: Government Regulation
Tobacco Industry
Tobacco Products
Advertising as Topic
Product Labeling
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

35. As funding for BPA research increased, NIEHS followed its peer review process while also exercising its discretion

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2017
Subject(s):: Peer Review
Phenols -- adverse effects
Research -- economics
Federal Government
Financing, Government
Humans
United States
United States. Department of Health and Human Services.
National Institutes of Health (U.S.)

36. Calculation of potential inflation-indexed rebates for Medicare Part B drugs

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2017
Subject(s):: Drug Costs
Insurance, Pharmaceutical Services -- economics
Medicare Part B -- economics
Cost Control
Cost Savings
Medicaid -- economics
Humans
United States
United States. Department of Health and Human Services.

37. Medicare Part B drug payments: impact of price substitutions based on 2014 average sales prices

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2017
Subject(s):: Drug Costs
Insurance, Health, Reimbursement
Insurance, Pharmaceutical Services
Medicare Part B -- economics
Cost Savings
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

38. Challenges appear to limit states' use of Medicaid payment suspensions

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
Subject(s):: Fraud -- prevention & control
Medicaid -- economics
State Government
Humans
United States
United States. Department of Health and Human Services.

39. Drug supply chain security: wholesalers exchange most tracing information

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
Subject(s):: Pharmaceutical Preparations -- supply & distribution
Prescription Drug Diversion
Information Dissemination
Security Measures
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

40. OHRP should inform potential complainants of how they can seek whistleblower protections:

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
Subject(s):: Human Experimentation
Research Subjects
Whistleblowing
Disclosure
Humans
United States
United States. Department of Health and Human Services.

« Previous
Next »
1
2
3
4
5
6
7
8
…
950
951